The chemokine family. Potential therapeutic targets from allergy to HIV infection

European Journal of Dermatology

Volumn 8, Issue 3, 1998, Pages 147-157

  Proudfoot, Amanda E I ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

Chemokine; Chemokine receptor antagonists; Chemokine receptors; HIV; Inflammation

Indexed keywords

CHEMOKINE; GLYCOSAMINOGLYCAN; SELECTIN;

ALLERGY; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; REVIEW; TARGET CELL;

ANIMALS; CHEMOKINES; GLYCOSAMINOGLYCANS; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 0031959764     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. [Review] [23 refs]. Cell 1991; 67: 1033-6.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. [Review] [105 refs]. Cell 1994; 76: 301-14
3. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazar JF, Moore KW, Schall TJ. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994; 266: 1395-9.
4. 3C motif. Nature 1997; 385: 640-4.
5. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma JY, Dussault B, Woolf E, Alperin G, Culpepper J, Gutierrez-Ramos JC, Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387: 611-7.
6. Wells TNC, Peitsch MC. The chemokine information source - identification and characterization of novel chemokines using the worldwide web and expressed sequence tag databases. J Leukocyte Biol 1997; 61: 545-50.
7. St Walz DA, Edwards BF. The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. J Biol Chem 1989; 264: 2092-9.
8. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three-dimensional structure of interleukin-8 in solution. Biochemistry 1990; 29: 1689-96.
9. Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenborn AM. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 1991; 88: 502-6.
10. Malkowski MG, Wu JY Lazar JB, Johnson PH, Edwards BF. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J Biol Chem 1995; 270: 7077-87.
11. Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R. The solution structure of melanoma growth stimulating activity. J Mol Biol 1994; 242: 252-70.
12. Lodi PJ, Garrett DS, Kuszewski J, Tsang ML, Weatherbee JA, Leonard WJ, Gronenborn AM, Clore GM. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. Science 1994; 263: 1762-7.
13. Skelton NJ, Aspiras F, Ogez J, Schall TJ. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry 1995; 34: 5329-42.
14. Chung CW, Cooke RM, Proudfoot AE, Wells TN. The three-dimensional solution structure of RANTES. Biochemistry 1995; 34: 9307-14.
15. Lubkowski J, Bujacz G, Boque L, Domaille PJ, Handel TM, Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat Struct Biol 1997; 4: 64-9.
16. Leong SR, Lowman HB, Liu J, Shire S, Deforge LE, Gillece-Castro BL, McDowell R, Hebert CA. IL-8 single-chain homodimers and heterodimers: Interactions with the chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci. 1997; 6: 609-17.
17. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. Neutrophil activation by monomeric interleukin-8. Science 1994; 264: 90-2.
18. Lowman HB, Fairbrother WJ, Slagle PH, Kabakoff R, Liu J, Shire S, Hebert CA. Monomeric variants of IL-8: Effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci 1997; 6: 598-608.
19. Zhang Y, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein-1 functions as a dimer. Mol Cell Biol 1995; 15: 4851-5.
20. Paolini JF, Willard D, Consler T, Luther M, Krangel MS. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol 1994; 153: 2704-17.
21. Kim KS, Rajarathnam K, Clark-Lewis I, Sykes BD. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett 1996; 395: 277-82.
22. Rot A. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol 1993; 23: 303-6.
23. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4: 394-400.
24. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark LI, Power CA, Wells TN. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997; 36: 13570-8.
25. Kuschert GS, Coulin F, Hubbard RE, Power CA, Wells TNC, Hoogewerf AJ. Soluble glycosoaminoglycans interact selectively with chemokines and inhibit 7-transmembrane chemokine receptor binding and cellular responses. J Leukocyte Biol 1998 (submitted).
26. Marquezini MV, Strunz CM, Dallan LA, Toledo OM. Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts. Cardiology 1995; 86: 143-6.
27. Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 1993; 36: 316-22.
28. Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, McNulty DE, Scott MO, Knutson JR, Porter D. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 1994; 33: 12741-5.
29. Power CA, Wells TN. Cloning and characterization of human chemokine receptors. [Review] [4 refs]. Trends Pharmacol Sci 1996; 17: 209-13.
30. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-9.
31. Oberlin E, Amara A, Bachelerie F Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833-5.
32. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/FUSIN and blocks HIV-1 entry. Nature 1996; 382: 829-33.
33. Power CA, Church DJ, Meyer A, Alouani S, Proudfoot AE, Clark, Sozzani S, Mantovani A, Wells TN. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 1997; 186: 825-35.
34. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama H, Yoshie O. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997; 272: 14893-8.
35. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 1997; 272: 13803-9.
36. Tiffany HL, Lautens LL, Gao JL, Pease J, Locati M, Combadiere C, Modi W, Bonner TI, Murphy PM. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med 1997; 186: 165-70.
37. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-30.
38. Murphy PM. Molecular piracy of chemokine receptors by Herpes viruses. [Review] [151 refs]. Infectious Agents & Disease 1994; 3: 137-54.
39. Wells TC, Schwartz TW. Plagiarism of the host immune system - lessons about chemokine immunology from viruses [Review]. Curr Opin Biotechnol 1997; 8: 741-8.
40. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995; 269: 1727-30.
41. Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 1996; 271: 2832-8.
42. Turner L, Ward SG, Westwick J. RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase. J Immunol 1995; 155: 2437-44.
43. Amara A, Legall S, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzanaseisdedos F. HIV coreceptor downregulation as antiviral principle - SDF-1-alpha-dependent internalization of me chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997; 186: 139-46.
44. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. [Review] [471 refs]. Adv Immunol 1994; 55: 97-179.
45. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper, Dzuiba J, van Damme J, Walz A, Marriott D. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-57.
46. + progenitors to peripheral blood. J Exp Med 1997; 185: 111-20.
47. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-8.
48. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992; 149: 636-42.
49. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994; 152: 1298-303.
50. Elsner J, Hochstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 1996; 26: 1919-25.
51. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. [Review] [33 refs]. J Leukocyte Biol 1996; 59: 81-9.
52. Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K. RANTES and macrophage inflammatory protein-1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996; 183: 2397-402.
53. Graham GJ Pragnell IB. SCI/MIP-1 alpha: a potent stem cell inhibitor with potential roles in development. [Review] [25 refs]. Developmental Biology 1992; 151: 377-81.
54. Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, van Damme J, Valitutti S, Lanzavecchia A, Mantovani A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 1995; 155: 3292-5.
55. Xu LL, Warren MK, Rose WL, Gong W, Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukocyte Biol 1996; 60: 365-71.
56. Mattoli S, Ackerman V, Vittori E, Marini M. Mast cell chemotactic activity of RANTES. Biochem Biophy Res Commun 1995; 209: 316-21.
57. Schweizer RC, Welmers BA, Raaijmakers JA, Zonen P, Lammers JW, Koenderman L. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 1994; 83: 3697-704.
58. Bonecchi R, Polentarutti N, Luini W, Borsatti A, Bernasconi S, Proudfoot AEI, Wells TNC, Mackay CR, Mantovani A, Sozzani S. Upregulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by Interferon gamma in human neutrophils. J Exp Med 1998 (in press).
59. Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes [see comments]. J Exp Med 1996; 184: 569-77.
60. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996, 153: 1398-404.
61. Davies RJ, Wang JH, Trigg CJ, Devalia JL. Expression of granulocyte/macrophage-colony-stimulating factor, interleukin-8 and RANTES in the bronchial epithelium of mild asthmatics is down-regulated by inhaled beclomethasone dipropionate. Int Arch Allergy Immunol 1996; 107: 428-9.
62. Folkard SG, Westwick J, Millar AB. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 1997, 10: 2097-104.
63. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Walz A, Strieter RM. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 1994; 94: 1012-8.
64. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398-407.
65. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, Baroody F, Bochner BS, Schleimer RP. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996; 98: 766-80.
66. Schroder JM. Cytokine networks in the skin. [Review] [43 refs]. J Invest Dermatol 1995; 105: 20S-4S.
67. Muller-Ladner U, Jones JL, Wetsel RA, Gay S, Raine CS, Barnum SR. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J Neur Sciences 1996; 144: 135-41.
68. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-7.
69. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberq D. Expression of monocyte chemoattractant protein-1 in macrophage-ricn areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-6.
70. Li D, Wang D, Griffiths-Johnson DA, Wells NC, Williams TJ, Jose PJ, Jeffery PK. Eotaxin protein and gene expression in guinea-pig lungs -constitutive expression and upregulation after allergen challenge. Eur Respir J 1997; 10: 1946-54.
71. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, Siegelman MH, Cybulsky M, Gutierrez-Ramos JC. Eosinophil recruitment to the lung in a murine model of allergic inflammation. Trie role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996; 98: 2332-45.
72. Standiford TJ, Kunkel SL, Lukacs NW, Greenberger MJ, Danforth JM, Kunkel RG, Strieter RM. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol 1995; 155: 1515-24.
73. Coyle AJ, Kips J, Hoogewerf AJ, Pauwels R, Tyers MD, Chvatchko Y, Power CA, Proudfoot AEI, Wells TNC. Upregulation of chemokine receptors in the airways after allergen provocation: Inhibition of airway inflammation and altered airway responsiveness by Met-RANTES, a chemokine receptor antagonist. J Exp Med 1998 (in press).
74. Plater ZC, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Imunol Lett 1997; 57: 117-20.
75. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197: 1167-72.
76. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-74.
77. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997, 186: 601-12.
78. Meurer R, van Riper G, Feeney W, Cunningham P, Hora D, Springer MS Jr, MacIntyre DE, Rosen H. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein-1, human macrophage inflammatory protein-1 alpha, or human interleukin-8. J Exp Med 1993; 178: 1913-21.
79. Beck LA, Dalke S, Leiferman KM, Bickel CA, Hamilton R, Rosen H, Bochner BS, Schleimer RP. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. J Immunol 1997; 159: 2962-72.
80. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995; 155: 4838-43.
81. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell R, Rollins BJ. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol 1997; 159: 401-8.
82. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995; 269: 1583-5.
83. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997; 185: 785-90.
84. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog [see comments] [published erratum appears in Science 1995 Oct 20; 270(5235): 365]. Science 1994, 265: 682-4.
85. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon CJ, Murphy PM. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997; 185: 1959-68.
86. Schall TJ, Simpson NJ, Mak JY. Molecular cloning and expression of the murine RANTES cytokine: structural and functional conservation between mouse and man. Eur J Immunol 1992; 22: 1477-81.
87. Campbell EM, Proudfoot AEI, Yoshimura T, Allet B, Wells TNC, White AM, Westwick J, Watson ML. Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. J Immunol 1997; 159: 1482-9.
88. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995; 96: 107-16.
89. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 1997; 76: 375-84.
90. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, Gutierrez-Ramos JC. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371-80.
91. Gong JH, Uguccioni M, Dewald B, Baggiolini M, Clark-Lewis I. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 1996; 271: 10521-7.
92. Gong JH, Clark-Lewis I. Antagonists of monocyte chemoattractant protein-1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 1995; 181: 631-40.
93. Proudfoot AE, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, Offord RE, Wells TN. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 1996; 271: 2599-603.
94. Gong JH, Ratkay LJ, Waterfield JD, Clark LI. An antagonist of monocyte chemoattractant protein-1 (MCP-1) inhibits arthritis in me MRL-Ipr mouse model. J Exp Med 1997; 186: 131-7.
95. Coyle AJ, Le Gros G, Bertrand C, Tsuyuki S, Heusser CH, Kopf M, Anderson GP. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995; 13: 54-9.
96. Berger EA. HIV entry and tropism - the chemokine receptor connection (Review). AIDS 1997; 11: 53-516.
97. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science 1996; 272: 872-7.
98. + T cells. Science 1995; 270: 1811-5.
99. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272: 1955-8.
100. Clapham PR. HIV and chemokines ligands sharing cell-surface receptors. Trends Cell Biol 1998; 7: 264-8.
101. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TN, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996; 87: 745-56.
102. Wells TN, Proudfoot AE, Power CA, Marsh M. Chemokine receptors - the new frontier for AIDS research. [Review] [35 refs]. Chem Biol 1996; 3: 603-9.
103. Schmidtmayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996; 382: 767.
104. Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B, Baggiolini B. HIV blocked by chemokine antagonist [letter]. Nature 1996; 383: 400.
105. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TC, Proudfoot AI. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997; 276: 276-9.
106. Mack M, Luckow BNP, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Strassinger M, Borlat F, Wells TNC, Schlondorff D, Proudfoot AEI. AOP-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechainism of HIV infectivity. J Exp Med 1998; (in press).
107. Signoret N, Oldridge J, Pelchen MA, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther, Wells TN, Hoxie JA, Marsh M. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997; 139: 651-64.
108. McKinnon M, Proudfoot AEI, Wells TNC, Solari R. Strategies for the discovery of cytokine receptor antagonists. Drug News Perspect 1996; 9: 389-98.
109. Schols D, Struyf S, Van DJ, Este JA, Henson G, de Clerq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186: 1383-8.
110. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Medicine 1996; 2: 412-7.
111. Garred P, Eugen-Olsen J, Iversen AK, Benfield TL, Svejgaard A, Hofmann B. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group [letter]. Lancet 1997; 349: 1884.